REFRACTORY CLASSIC HODGKIN LYMPHOMA
Clinical trials for REFRACTORY CLASSIC HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY CLASSIC HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY CLASSIC HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test new drug duo in fight against tough lymphomas
Disease control OngoingThis early-stage study is testing a combination of two drugs, pembrolizumab and vorinostat, for people with certain types of lymphoma that have come back or not responded to prior treatments. The main goals are to check the safety of the combination and find the best dose of vori…
Matched conditions: REFRACTORY CLASSIC HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug cocktail tested to fight Tough-to-Treat blood cancer
Disease control OngoingThis study is testing combinations of three drugs—brentuximab vedotin, nivolumab, and ipilimumab—to see if they work better together to control Hodgkin lymphoma that has come back or hasn't responded to previous treatments. It involves 146 patients aged 12 and older and aims to f…
Matched conditions: REFRACTORY CLASSIC HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC